Vow’s first product brand, Morsel, is a cultured umami quail product slated for Singapore restaurants by the end of the year. The company focuses on creating meat from animal cells as a more sustainable alternative and previously targeted exotic meats such as buffalo, kangaroo and alpaca. Vow raised $49.2 million in a Series A to accelerate scaling and manufacturing, which the company identifies as its largest single cost. Its Factory 1 currently produces between roughly 1 kilo and tens of kilos every few days, and Vow is developing a second factory it describes as '100x larger.' When fully operational the company has said a facility could produce as much as 30 tonnes (66,100 pounds) of cultivated meat per year. Vow plans to use the new capital to speed Morsel’s market introduction, advance product development and hire across product, marketing and manufacturing; it expects manufacturing headcount to grow from four to 15–20 and overall headcount to reach about 80 by mid next year. The company is pursuing regulatory approval in Singapore and Australia and says the U.S. timeline is less clear. Vow is an Australian cellular-agriculture startup founded in 2019 by Tim Noakesmith and George Peppou. The company builds a proprietary cell library of animal genetic material to develop cultured meat from species ranging from kangaroo to alpaca, water buffalo, goat, pig, and rabbit. Vow emphasizes vertically integrated control of the end-to-end process, from cell-line identification through product development. Its product strategy targets premium, niche experiences initially with a goal of scaling to mass-market consumers. With fresh seed capital, the company is pursuing regulatory clearances to bring products to consumers and is initially targeting faster-moving Asian regulators and markets. The team positions its approach as enabling novel combinations optimized for flavor, nutrition, sustainability, and cost.

Total raised

$55M

Funding rounds

2

Latest round

Series A

Latest activity

Nov 2022